BRCA1/2 MUTATION

Clinical trials for BRCA1/2 MUTATION explained in plain language.

Never miss a new study

Get alerted when new BRCA1/2 MUTATION trials appear

Sign up with your email to follow new studies for BRCA1/2 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for pancreatic cancer: targeted combo trial for BRCA/PALB2 patients

Disease control Recruiting now

This study tests a new combination of chemotherapy drugs (NABPLAGEM) against the standard combo for people with advanced pancreatic cancer that has a BRCA1/2 or PALB2 gene mutation. The goal is to see if the new combo works better at shrinking tumors and helping people live longe…

Matched conditions: BRCA1/2 MUTATION

Phase: PHASE2, PHASE3 • Sponsor: University Health Network, Toronto • Aim: Disease control

Last updated May 15, 2026 11:57 UTC

BRCA1/2 MUTATION

Get alerted when new BRCA1/2 MUTATION trials appear

New hope for pancreatic cancer: targeted combo trial for BRCA/PALB2 patients